advanced search

Synolus Medical

Synolus Medical is developing MiniGo™, an on-body biologics delivery platform designed for both handheld and hands-free administration within the same device architecture. The platform supports 1–15 mL injected volumes and ultra-high-viscosity formulations.


Visit Website

Headquarters
Synolus Medical Inc
321 Ballenger Center Drive, STE125
Frederick, MD 21703
United States

Synolus Medical is the medical technology company behind MiniGo™, a standardised on-body biologics delivery platform designed for both handheld and hands-free administration within the same device architecture. The platform supports 1–15 mL injected volumes and ultra-high-viscosity formulations, powered by OmniDrive™ self-regulating flow.

MiniGo’s prefilled and preassembled architecture requires no molecule-specific customisation and supports therapies from pharmaceutical development through patient self-administration.

Synolus Medical is privately owned.

Authors and Contacts

Dr Scott Russo
Founder and Chief Executive Officer
Synolus Medical

Article

WEARABLES
Dr Scott Russo
LIMITS SHATTERED: ENDING THE AUTOINJECTOR AND WEARABLE INJECTOR DIVIDE
Dr Scott Russo questions the distinction between wearable injectors and autoinjectors, making the case that it is not fundamental to device design, rather it is an outdated segmentation that results in unnecessary design trade-offs. He introduces MiniGo, a next-generation platform device that aims to overcome this false dichotomy.
Top